Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases (original) (raw)
Hague SM, Klaffke S, Bandmann O . Neurodegenerative disorders: Parkinson's disease and Huntington's disease. J Neurol Neurosurg Psychiatry 2005; 76: 1058–63. CASPubMedPubMed Central Google Scholar
Javitt DC, Zukin SR . The role of excitatory amino acids in neuropsychiatric illness. J Neuropsychiatry Clin Neurosci 1990; 2: 44–52. CASPubMed Google Scholar
Berliocchi L, Bano D, Nicotera P . Ca2+ signals and death programmes in neurons. Philos Trans R Soc Lond B Biol Sci 2005; 360: 2255–8. CASPubMedPubMed Central Google Scholar
Wong PC, Cai H, Borchelt DR, Price DL . Genetically engineered mouse models of neurodegenerative diseases. Nat Neurosci 2002; 5: 633–9. CASPubMed Google Scholar
Sims NR, Zaidan E . Biochemical changes associated with selective neuronal death following short-term cerebral ischaemia. Int J Biochem Cell Biol 1995; 27: 531–50. CASPubMed Google Scholar
Danysz W, Parsons CG . The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence. Int J Geriatr Psychiatry 2003; 18: 23–32. Google Scholar
Ndountse LT, Chan HM . Role of _N_-methyl-_D_-aspartate receptors in polychlorinated biphenyl mediated neurotoxicity. Toxicol Lett 2009; 184: 50–5. CASPubMed Google Scholar
Jung KH, Chu K, Lee ST, Park HK, Kim JH, Kang KM, et al. Augmentation of nitrite therapy in cerebral ischemia by NMDA receptor inhibition. Biochem Biophys Res Commun 2009; 378: 507–12. CASPubMed Google Scholar
Fan MMY, Raymond LA . N-Methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease. Neurobiology 2007; 81: 272–93. CAS Google Scholar
Handley OJ, Naji JJ, Dunnett SB, Rosser AE . Pharmaceutical, cellular and genetic therapies for Huntington's disease. Clin Sci 2006; 110: 73–88. CASPubMed Google Scholar
Van Damme P, Bogaert E, Dewil M, Hersmus N, Kiraly D, Scheveneels W, et al. Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity. Proc Natl Acad Sci USA 2007; 104: 14825–30. CASPubMed Google Scholar
Wu HY, Tomizawa K, Oda Y . Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. Biol Chem 2004; 279: 4929–40. CAS Google Scholar
Wang Y, Han R, Liang ZQ, Wu JC, Zhang XD, Gu ZL, et al. An autophagic mechanism is involved in apoptotic death of rat striatal neurons induced by the non-_N_-methyl-_D_-aspartate receptor agonist kainic acid. Autophagy 2008; 4: 214–26. CASPubMed Google Scholar
Wang Y, Gu ZL, Cao Y, Liang ZQ, Han R, Bennett MC, et al. Lysosomal enzyme cathepsin B is involved in kainic acid–induced excitotoxicity in rat striatum. Brain Res 2006; 1071: 245–9. CASPubMed Google Scholar
Friedman LK . Calcium: a role for neuroprotection and sustained adaptation. Mol Interv 2006; 6: 315–29. PubMed Google Scholar
Lee HG, Zhu X, Casadesus G, Pallàs M, Camins A, O'Neill MJ, et al. The effect of mGluR2 activation on signal transduction pathways and neuronal cell survival. Brain Res 2009; 1249: 244–50. CASPubMed Google Scholar
Yadava N, Nicholls DG . Spare respiratory capacity rather than oxidative stress regulates glutamate excitotoxicity after partial respiratory inhibition of mitochondrial complex i with rotenone. J Neurosci 2007; 27: 7310–7. CASPubMed Google Scholar
Qin ZH, Tao LY, Chen X . Dual roles of NF-κB in cell survival and implications of NF-κB inhibitors in neuroprotective therapy. Acta Pharmacol Sin 2007; 28: 1859–72. CASPubMed Google Scholar
Beck J, Lenart B, Kintner DB, Sun D . Na-K-Cl cotransporter contributes to glutamate-mediated excitotoxicity. J Neurosci 2003; 23: 5061–8. CASPubMed Google Scholar
Chen Q, Olney JW, Lukasiewicz PD, Almli T, Romano C . Ca2+-independent excitotoxic neurodegeneration in isolated retina, an intact neural net: a role for Cl− and inhibitory transmitters. Mol Pharmacol 1998; 53: 564–72. CASPubMed Google Scholar
Olney JW, Price MT, Samson L, Labruyere J . The role of specific ions in glutamate neurotoxicity. Neurosci Lett 1986; 65: 65–71. CASPubMed Google Scholar
Inglefield JR, Schwartz-Bloom RD . Optical imaging of hippocampal neurons with a chloride-sensitive dye: early effects of in vitro ischemia. J Neurochem 1998; 70: 2500–9. CASPubMed Google Scholar
Staub F, Stoffel M, Berger S, Eriskat J, Baethmann A . Treatment of vasogenic brain edema with the novel Cl− transport inhibitor torasemide. J Neurotrauma 1994; 11: 679–90. CASPubMed Google Scholar
Lee BK, Lee DH, Park S, Park SL, Yoon JS, Lee MG, et al. Effects of KR-33028, a novel Na+/H+ exchanger-1 inhibitor, on glutamate-induced neuronal cell death and ischemia-induced cerebral infarct. Brain Res 2009; 1248: 22–30. CASPubMed Google Scholar
Wang HG, Pathan N, Ethell IM, Kjrajewski S, Yamaguchi Y, Shibasaki F, et al. Ca2+ induced apoptosis through calcineurin dephosphorylation of BAD. Science 1999; 284: 339–43. CASPubMed Google Scholar
Youn HD, Sun L, Prywes R, Liu JO . Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. Science 1999; 286: 790–3. CASPubMed Google Scholar
Szado T, Vanderheyden V, Parys JB, De Smedt H, Rietdorf K, Kotelevets L, et al. Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca2+ release and apoptosis. Proc Natl Acad Sci USA 2008; 105: 2427–32. CASPubMed Google Scholar
Nixon RA . A “Protease Activation Cascade” in the Pathogenesis of Alzheimer's Disease. Ann NY Acad Sci 2000; 924: 117–31. CASPubMed Google Scholar
Wang KK . Calpain and caspase: can you tell the difference? Trends Neurosci 2000; 23: 20–6. PubMed Google Scholar
Ichinose T, Yu S, Wang XQ, Yu SP . Ca2+-independent, but voltage - and activity-dependent regulation of the NMDA receptor outward K+ current in mouse cortical neurons. J Physiol 2003; 551: 403–17. CASPubMedPubMed Central Google Scholar
Nicholls DG . Mitochondrial dysfunction and glutamate excitotoxicity studied in primary neuronal cultures. Curr Mol Med 2004; 4: 149–77. CASPubMed Google Scholar
Farooqui T, Farooqui AA . Aging: an important factor for the pathogenesis of neurodegenerative diseases. Mech Ageing Dev 2009; 130: 203–15. CASPubMed Google Scholar
Albers DS, Swerdlow RH, Manfredi G, Gajewski C, Yang L, Parker WD, et al. Further evidence for mitochondrial dysfunction in progressive supranuclear palsy. Exp Neurol 2001; 168: 196–8. CASPubMed Google Scholar
Gilgun-Sherki Y, Rosenbaum Z, Melamed E, Offen D . Antioxidant therapy in acute central nervous system injury: current state. Pharmacol Rev 2002; 54: 271–84. CASPubMed Google Scholar
Porta S, Serra SA, Huch M, Valverde MA, Llorens F, Estivill X, et al. RCAN1 (DSCR1) increases neuronal susceptibility to oxidative stress: a potential pathogenic process in neurodegeneration. Hum Mol Genet 2007; 16: 1039–50. CASPubMed Google Scholar
Fridovich I . Superoxide anion radical (O2–), superoxide dismutases, and related matters. J Biol Chem 1997; 272: 18515–7. CASPubMed Google Scholar
Law A, Gauthier S, Quirion R . Say NO to Alzheimer's disease, the putative links between nitric oxide and dementia of Alzheimer's type. Brain Res Rev 2001; 35: 73–96. CASPubMed Google Scholar
Brown G, Bal-Price A . Inflammatory neurodegeneration mediated by nitric oxide, glutamate and mitochondria. Mol Neurobiol 2003; 27: 325–55. CASPubMed Google Scholar
Parathath SR, Parathath S, Tsirka SE . Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice. J Cell Sci 2005; 119: 339–49. Google Scholar
Wei C, Qin ZH, Zhang HL . Matrix metalloproteinases and nervous diseases. Chin Pharmacol Bull 2007; 23: 8–12. CAS Google Scholar
Berman SB, Hastings TG . Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria, implications for Parkinson's disease. J Neurochem 1999; 73: 1127–37. CASPubMed Google Scholar
Halestrap AP, Doran E, Gillespie JP, O'Toole A . Mitochondria and cell death. Biochem Soc Trans 2000; 28: 170–7. CASPubMed Google Scholar
Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, et al. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 2000; 288: 870–4. CAS Google Scholar
Luo Y, Hattori A, Munoz J, Qin ZH, Roth GS . Intrastriatal dopamine injection induces apoptosis through oxidation-involved activation of transcription factors AP-1 and NF-kappaB in rats. Mol Pharmacol 1999; 56: 254–64. CASPubMed Google Scholar
Maalouf M, Sullivan PG, Davis L, Kim DY, Rho JM . Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience 2007; 145: 256–64. CASPubMedPubMed Central Google Scholar
Morgan MJ, Kim YS, Liu ZG . Lipid rafts and oxidative stress-induced cell death. Antioxidants Redox Signal 2007; 9: 1471–84. CAS Google Scholar
Duchen MR . Roles of mitochondria in health and disease. Diabetes 2004; 53: 96–102. Google Scholar
Orrenius S . Mitochondrial regulation of apoptotic cell death. Toxicol Lett 2004; 149: 19–23. CASPubMed Google Scholar
Yan CH, Liang ZQ, Gu ZL, Yang YP, Reid P, Qin ZH . Contributions of autophagic and apoptotic mechanisms to CrTX-induced death of K562 cells. Toxicon 2006; 47: 521–30. CASPubMed Google Scholar
Kim I, Rodriguez-Enriquez S, Lemasters JJ . Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys 2007; 462: 245–53. CASPubMedPubMed Central Google Scholar
Kazuhiko N, Osamu Y, Kinya O . Crosstalk between autophagy and apoptosis in heart disease. Circ Res 2008; 103: 343–51. Google Scholar
Qin ZH, Wang Y, Nakai M, Chase TN . Activation of transcription factor NF-κB contributes to excitotoxin–induced apoptosis. Mol Pharmacol 1998; 53: 33–42. CASPubMed Google Scholar
Qin ZH, Wang Y, Nakai M, Chen RW, Chuang DM, Chase TN . Co-stimulation of cyclic-AMP-linked metabotropic glutamate receptors in rat striatum attenuates excitotoxin-induced nuclear factor-κB activation and apoptosis. Neuroscience 1999; 94: 1153–62. PubMed Google Scholar
Kessler DJ, Duyao MP, Spicer DB, Sonenshei GE . NF-κB-like factors mediate interleukin 1 induction of c-Myc gene transcription in fibroblasts. J Exp Med 1992; 176: 787–92. CASPubMed Google Scholar
Wu H, Lozano G . NF-κB activation of p53, a potential mechanism for suppressing cell growth in response to stress. J Biol Chem 1994; 269: 20067–74. CASPubMed Google Scholar
Lee H, Arsura M, Wu M, Duyao M, Buckler AJ, Sonenshein GE . Role of Rel-related factors in control of c-Myc gene transcription in receptor-mediated apoptosis of marine B cell WEHI 231 line. J Exp Med 1995; 181: 1169–77. CASPubMed Google Scholar
O'Connor JC, Wallace DM, O'Brien CJ, Cotter TG . A novel antioxidant function for the tumor–suppressor gene p53 in the retinal ganglion cell. Investig Ophthalmol Visual Sci 2008; 49: 4237–44. Google Scholar
Yuan J, Yankner BA . Apoptosis in the nervous system. Nature 2000; 407: 802–9. CASPubMed Google Scholar
Navarro A, Boveris A . The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol 2007; 292: 670–86. Google Scholar
Vonsattel JP, DiFiglia M . Huntington disease. J Neuropathol Exp Neurol 1998; 57: 369–84. CASPubMed Google Scholar
Deng P, Zhang Y, Xu ZC . Inhibition of _I_h in striatal cholinergic interneurons early after transient forebrain ischemia. J Cereb Blood Flow Metab 2008; 28: 939–47. CASPubMed Google Scholar
Li Y, Lei ZG, Xu ZC . Enhancement of inhibitory synaptic transmission in large aspiny neurons after transient cerebral ischemia. Neuroscience 2009; Jan 3. In Press.
Van Raamsdonk JM, Pearson J, Rogers DA, Bissada N, Vogl AW, Hayden MR, et al. Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease. Hum Mol Genet 2005; 14: 1379–92. CASPubMed Google Scholar
Zhang H, Li Q, Graham RK, Slow E, Hayden MR, Bezprozvanny I . Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease. Neurobiol Dis 2008; 31: 80–8. CASPubMedPubMed Central Google Scholar
Song C, Zhang Y, Parsons CG, Liu YF . Expression of polyglutamine-expanded huntingtin induces tyrosine phosphorylation of _N_-methyl-D-aspartate receptors. J Biol Chem 2003; 278: 33364–9. CASPubMed Google Scholar
Sun Y, Savanenin A, Reddy PH, Liu YF . Polyglutamine-expanded huntingtin promotes sensitization of _N_-methyl-_D_-aspartate receptors via post-synaptic density 95. J Biol Chem 2001; 276: 24713–8. CASPubMed Google Scholar
Zeron MM, Chen N, Moshaver A, Lee AT, Wellington CL, Hayden MR, et al. Mutant huntingtin enhances excitotoxic cell death. Mol Cell Neurosci 2001; 17: 41–53. CASPubMed Google Scholar
Liang ZQ, Wang XX, Wang YM, Chang DM, DiFiglia M, Chase TN, et al. Susceptibility of striatal neurons to excitotoxic injury correlates with basal levels of bcl-2 and the induction of p53 and c-myc immunoreactivity. Neurobiol Dis 2005; 20: 562–73. CASPubMed Google Scholar
Coyle JT, Schwarcz R . Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea. Nature 1976; 263: 244–6. CASPubMed Google Scholar
McGeer EG, McGeer PL . Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids. Nature 1976; 63: 517–9. Google Scholar
Nakai M, Qin ZH, Chen JF, Wang Y, Chase TN . Kainic acid-induced apoptosis in rat striatum is associated with nuclear factor-κB activation. J Neurochem 2000; 74: 647–58. CASPubMed Google Scholar
Liang ZQ, Wang XX, Wang Y, Chen RW, Chuang DM, Chase TN, et al. NF-κB-dependent cyclin D1 induction associated with _N_-methyl-_D_-aspartate receptor-mediated apoptosis in rat striatum. J Neurosci Res 2007; 85: 1295–309. CASPubMed Google Scholar
Qin ZH, Chen RW, Wang Y, Nakai M, Chuang DM, Chase TN . NF-κB nuclear translocation up-regulates c-Myc and p53 during _N_-methyl-_D_-aspartate receptor-mediatedapoptosis. J Neurosci 1999; 19: 4023–33. CASPubMed Google Scholar
Busciglio J, Yankner BA . Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 1995; 378: 776–9. CASPubMed Google Scholar
Robinson SR, Bishop GM . Aß as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease. Neurobiol Aging 2002; 23: 1051–72. CASPubMed Google Scholar
Parameshwaran K, Dhanasekaran M, Suppiramaniam V . Amyloid beta peptides and glutamatergic synaptic dysregulation. Exp Neurol 2008; 210: 7–13. CASPubMed Google Scholar
Jinno S, Araki K, Matsumoto Y, Suh YH, Yamamoto T . Selective apoptosis induction in the hippocampal mossy fiber pathway by exposure to CT105, the C-terminal fragment of Alzheimer's amyloid precursor protein. Brain Res 2009; 1249: 68–78. CASPubMed Google Scholar
Nixon RA . Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci 2007; 120: 4081–91. CASPubMed Google Scholar
Parihar MS, Hemnani T . Alzheimer's disease pathogenesis and therapeutic Intervent. J Clin Neurosci 2004; 11: 456–67. CASPubMed Google Scholar
Hynd MR, Scott HL, Dodd PR . Glutamate mediated excitotoxicity and neurodegeneration in Alzheimer′s disease. Neurochem 2004; 45: 583–95. CAS Google Scholar
Kuo CT, Hsua MJ, Chen BC, Chen CC, Teng CM, Pan SL, et al. Denbinobin induces apoptosis in human lung adenocarcinoma cells via Akt inactivation, Bad activation, and mitochondrial dysfunction. Toxicol Lett 2008; 177: 48–58. CASPubMed Google Scholar
Miguel-Hidalgo JJ, Alvarez XA, Cacabelos R, Quack G . Neuroprotection by memantine against neurodegeneration induced by ß-amyloid1–40 . Brain Res 2002; 958: 210–21. CASPubMed Google Scholar
De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST, et al. Aß oligomers induce neuronal oxidative stress through an _N_-methyl-_D_-aspartate receptor-dependent mechanism that is blocked by the alzheimer drug memantine. J Biol Chem 2007; 282: 11590–601. CASPubMed Google Scholar
Obeso JA, Olanou CW, Nutt JG . Levodopa motor complications in Parkinson's disease. Trends Neurosci 2000; 23: 2–7. Google Scholar
Mouradian MM . Recent advances in the genetics and pathogenesis of Parkinson disease. Neurology 2002; 58: 179–85. PubMed Google Scholar
Jenner P . Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov Disord 1998; 13: 24–34. PubMed Google Scholar
Zhang W, Wang TG, Pei Z, Miller DS, Wu XF, Block ML, et al. Aggregated-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J 2005; 19: 533–42. CASPubMed Google Scholar
Helton TD, Otsuka T, Lee MC, Mu YY, Ehlers MD . Pruning and loss of excitatory synapses by the Parkin ubiquitin ligase. Proc Natl Acad Sci USA 2008; 105: 19492–7. CASPubMed Google Scholar
Lang AE, Lozano AM . Parkinson's disease-first of two parts. Med Prog 1998; 339: 1044–53. CAS Google Scholar
Dauer W, Przedborski S . Parkinson's disease: mechanisms and models. Neuron 2003; 39: 889–909. CAS Google Scholar
Moring J, Niego LA, Ganley LM, Trumbore MW, Herbette LG . Interaction of the NMDA receptor noncompetitive antagonist mk-801 with model and native membranes. Biophys J 1994; 67: 2376–86. CASPubMedPubMed Central Google Scholar
Kooncumchoo P, Sharma S, Porter J, Govitrapong P, Ebadi M . Coenzyme Q (10) provides neuroprotection in iron-induced apoptosis in dopamine neurons. J Mol Neurosci 2006; 28: 125–41. CASPubMed Google Scholar
Obata T . Nitric oxide and MPP (t)-induced hydroxyl radical generation. J Neural Transm 2006; 113: 1131–44. CASPubMed Google Scholar
Aleyasin H, Rousseaux MW, Phillips M, Kim RH, Bland RJ, Callaghan S, et al. The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage. Proc Natl Acad Sci USA 2007; 104: 18748–53. CASPubMed Google Scholar